Original language | English (US) |
---|---|
Pages (from-to) | E72-E75 |
Journal | Haematologica |
Volume | 105 |
Issue number | 2 |
DOIs | |
State | Published - Jan 31 2020 |
ASJC Scopus subject areas
- Hematology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Haematologica, Vol. 105, No. 2, 31.01.2020, p. E72-E75.
Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Variable global distribution of cell-of-origin from the ROBUST phase III study in diffuse large B-cell lymphoma
AU - Nowakowski, Grzegorz S.
AU - Chiappella, Annalisa
AU - Witzig, Thomas E.
AU - Scott, David W.
AU - Spina, Michele
AU - Gascoyne, Randy D.
AU - Zhang, Lei
AU - Russo, Jacqueline
AU - Kang, Janet
AU - Zhang, Jingshan
AU - Xu, Yingyong
AU - Vitolo, Umberto
N1 - Funding Information: 1Division of Hematology, Mayo Clinic, Rochester, MN, USA; 2Division of Hematology, Città della Salute e della Scienza Hospital and University, Torino, Italy; 3Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada; 4Division of Medical Oncology A, National Cancer Institute, Aviano, Italy and 5Celgene Corporation, Summit, NJ; USA Acknowledgments: we thank all of the co-investigators on the ROBUST clinical study; patients, families, and caregivers who are participating in the study; and support from Celgene Corporation for sponsoring the study. This work was supported by Celgene Corporation, Summit, NJ, USA and is a joint scientific collaboration
PY - 2020/1/31
Y1 - 2020/1/31
UR - http://www.scopus.com/inward/record.url?scp=85078815823&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85078815823&partnerID=8YFLogxK
U2 - 10.3324/haematol.2019.220475
DO - 10.3324/haematol.2019.220475
M3 - Letter
C2 - 31221781
AN - SCOPUS:85078815823
SN - 0390-6078
VL - 105
SP - E72-E75
JO - Haematologica
JF - Haematologica
IS - 2
ER -